Number of peripheral blood regulatory T cells and lymphocyte activation at 3 months after conversion to mtor inhibitor therapy

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 2871-2873

  San Segundo, D ^a   Fernandez Fresnedo, G ^a   Gago, M ^a   Beares, I ^a   Ruiz Criado, J ^a   Gonzalez, M ^a   Ruiz, J C ^a   Gomez Alamillo C ^a   Arias, M ^a   Lopez Hoyos M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DIAGNOSTIC KIT; FEMALE; FLOW CYTOMETRY; HUMAN; INFECTION RISK; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY; TOR SERINE-THREONINE KINASES;

EID: 77958545416     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.045     Document Type: Article

References (6)

1. M. Guba, J. Pratschke, C. Hugo SMART Study Group Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitorbased quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial [published online ahead of print May 11, 2010] Transplantation 2010
2. T. Taner, H. Hackstein, and Z. Wang Rapamycin-treated, alloantigen-pulsed host dendritic cells induce age-specific T cell regulation and prolong graft survival Am J Transplant 5 2005 228
3. D. Valmori, V. Tosello, and N.E. Souleimanian Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells J Immunol 177 2006 944
4. A.L. Taylor, R. Marcus, and J.A. Bradley Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation Crit Rev Oncol Hematol 56 2005 155
5. D.S. Segundo, G. Fernandez-Fresnedo, and J.C. Ruiz Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients Transplantation 82 2006 550
6. R.J. Kowalski, D.R. Post, and R.B. Mannon Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay Transplantation 82 2006 663